A detailed history of Silvercrest Asset Management Group LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 35,700 shares of CLPT stock, worth $192,423. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,700
Previous 35,700 -0.0%
Holding current value
$192,423
Previous $242,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$7.09 - $13.65 $46,085 - $88,725
6,500 Added 22.26%
35,700 $466,000
Q1 2022

May 16, 2022

BUY
$7.8 - $11.6 $31,200 - $46,400
4,000 Added 15.87%
29,200 $304,000
Q3 2021

Nov 15, 2021

BUY
$16.58 - $22.25 $24,869 - $33,375
1,500 Added 6.33%
25,200 $447,000
Q1 2020

May 15, 2020

BUY
$3.33 - $6.14 $78,921 - $145,518
23,700 New
23,700 $85,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $132M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.